CD274 and melanoma: To define the potential role of PD1/PD‐L1 inhibitory interaction in the NK‐cell‐mediated lysis of melanoma BRAFi‐resistant variants anti PD1 antibodies were used to block the interaction of PD‐1 with its ligand PD‐L1.